Form 4: ANI Pharmaceuticals Senior VP Sells Shares Under Pre-Arranged Trading Plan

Meredith Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals Inc. (ANIP), sold 400 shares of common stock for $61.37 per share, as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals Inc. (ANIP), reported a sale of common stock.
• The transaction involved the disposition of 400 shares of ANIP common stock.
• The shares were sold at a price of $61.37 per share.
• The sale occurred on June 13, 2025.
• Following this transaction, Meredith Cook beneficially owns 79,345 shares of ANI Pharmaceuticals common stock directly.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on September 17, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, which can sometimes be negative, the fact that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates concerns about its implications for the company's immediate future. The volume of shares sold is also relatively small compared to the total holdings.

Negatives

• Insider selling, even under a pre-arranged plan, can sometimes be perceived negatively by investors as it may suggest a lack of confidence in the company's future prospects, although the small volume in this instance mitigates this concern.

Management Comments

• The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It is specific to the individual company and its executive's personal trading activities.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a slight negative signal, though the pre-arranged nature of the sale under a 10b5-1 plan typically reduces this concern. The relatively small number of shares sold compared to total holdings also limits the perceived impact.

Key Dates

Keywords

ANI Pharmaceuticals, ANIP, SEC Form 4, Insider Trading, Stock Sale, Meredith Cook, Rule 10b5-1 Plan, Corporate Officer, Pharmaceuticals